SLC5A2 and type 1 diabetes mellitus: Some studies have shown that SGLT2 inhibitors resulted in a gradual recovery and stabilization of renal function after reducing glomerular hyperfiltration in human patients with T1DM (Nespoux & Vallon, 2018; Vallon et al., 2013).